Revance Therapeutics Prices 3.25M Share Offering @$36.00/Share By: Benzinga via Benzinga November 04, 2015 at 04:23 AM EST Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced the pricing of its underwritten public offering of 3,250,000 shares of its ... Read More >> Related Stocks: Revance Therapeutics